Beacon Impatiens 2021 Donation Supports Two Charities Fighting Pulmonary Fibrosis

December 29, 2021 PanAmerican Seed

PanAmerican Seed is pleased to confirm its 2021 charitable donation reached $81,000.00 thanks to proceeds of its Beacon® Impatiens global seed sales. The donation has been presented to two worthy organizations fighting Pulmonary Fibrosis, a progressive and deadly lung disease. The Canadian Pulmonary Fibrosis Foundation (CPFF) and the Dutch Association of Pulmonary Fibrosis Patients (Pendersfonds) each received a check for $40,725.00 (US) on behalf of PanAmerican Seed and Beacon Impatiens.

Beacon Impatiens Seed Sales Will Help Fight Lung Disease in 2021

February 3, 2021 PanAmerican Seed

As part of its product launch promise, Beacon Impatiens brings light – and happiness – back to shade gardens worldwide. In that spirit, PanAmerican Seed is proud to announce its next Beacon charitable donation will go towards the fight against Pulmonary Fibrosis (PF), a progressive and deadly lung disease.

Beacon Impatiens Will Star In Tu Bloom’s Designs for the 62nd Annual GRAMMY Awards

January 8, 2020 PanAmerican Seed

World-class flower breeder PanAmerican Seed® is proud to announce its NEW Beacon® Impatiens will bring the red carpet to life as the showcase floral selected by Tu Bloom Designs®, the official Botanical Artist for the GRAMMY Awards®.

U.S. Utility Patent Granted For Beacon Impatiens

June 13, 2019 PanAmerican Seed

PanAmerican Seed® is thrilled to announce that a United States utility patent was granted for its new Beacon™ Impatiens having a unique form of disease resistance to Impatiens downy mildew. US 10,285,362 covers all 6 colors and two mixes of Beacon Impatiens walleriana. Additional patent applications are pending.

New Website For Beacon Impatiens

March 6, 2019 PanAmerican Seed

PanAmerican Seed announces the launch of a new website devoted specifically to its NEW Beacon™ Impatiens, a series of I. walleriana with proven high resistance to Impatiens downy mildew. The website www.BeaconImpatiens.com appeals to many audiences, and includes special features, including the story behind this breakthrough product and the team who brought it to market, as well as details on the charitable donation of 3% of global Beacon sales, which will support Osteogenesis Imperfecta in the 2019-2020 sales season.